Reboxetine versus other antidepressive agents for depression

Rachel Churchill; Deborah M Caldwell; Hugh McGuire; Corrado Barbui; Andrea Cipriani; Toshi A Furukawa; Norio Watanabe; Glyn Lewis

doi:10.1002/14651858.CD007852.pub2

Alert

Some users are currently having issues accessing their saved searches, and not receiving their alerts. We are working on a fix and will update users as soon as possible.

If you are experiencing this issue, please contact [email protected]

The Cochrane Library

Trusted evidence. Informed decisions. Better health.

Browse Advanced search

Scolaris Language Selector Scolaris Language Selector

Scolaris Content Language Banner Portlet Scolaris Content Language Banner Portlet

Scolaris Content Display Scolaris Content Display

Reboxetine versus other antidepressive agents for depression

Version published: 19 October 2018 Version history

https://doi.org/10.1002/14651858.CD007852.pub2

Collapse all Expand all

Reason for withdrawal from publication

The planned review outlined in this protocol has not been successfully converted into a full Cochrane Review within established timelines and for this reason has been withdrawn by the Common Mental Disorders CRG from the CDSR.